Valerie Yang MBBChir PhD

Good friends and great science ftw!

[Valerie Yang MBBChir PhD @val_yang]

A full house at 1st SingHealth Sarcoma and Skin Symposium at the National Cancer Centre Singapore, 19-20 July 2023. Wonderful to see so many people from all walks of life dedicated towards improving outcomes for our patients with #Sarcoma or #Skin Cancers! #rarecancer

[ATLAS project by National Cancer Center, Japan @ATLAS_by_NCC]

🌟"ATLAS Monthly Webinar" series🌟
We are excited to announce the ATLAS Monthly Webinar!
This seminar series aims to share the latest advancements in cancer research, and treatment.
We look forward to your participation😊
Date: 2026/01/28
Registration: https://t.co/JTjPhCnSno

[Valerie Yang MBBChir PhD @val_yang]

@drdaviddwlee Congratulations David 👍💯

[OncoDaily @oncodaily]

Looking forward to discussing how we are pushing the boundaries in treating sarcomas and rare cancers - @val_yang
@saxotomy @ATLAS_by_NCC

https://t.co/LvKCCp0gZK

#Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

[Valerie Yang MBBChir PhD @val_yang]

How do we beat this devastating disease? Let’s talk! Thanks @ATLAS_by_NCC for the opportunity 💯💪

[ATLAS project by National Cancer Center, Japan @ATLAS_by_NCC]

🌟ATLAS Monthly Webinar🌟
Speaker Introduction
Dr. Valerie Yang
National Cancer Centre Singapore
Title: Combating Soft Tissue Sarcomas: Strategies for Impact

Date: March 27th, 2025
Registration: https://t.co/xjtnpYVBSO

[ATLAS project by National Cancer Center, Japan @ATLAS_by_NCC]

🌟"ATLAS Monthly Webinar" series🌟
We are excited to announce the ATLAS Monthly Webinar! This seminar series aims to share the latest advancements in cancer research, and treatment. We look forward to your participation😊
Date: 2025/03/27
Registration: https://t.co/xjtnpYW9Im

[OncoDaily @oncodaily]

💔Emotional Toll of Rare Cancers: Study by @val_yang Highlights the Need for Enhanced Support
@astar_research @CellbiologyT

https://t.co/o3MyRpAMpH

#RareCancer #PatientSupport #Cancer #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

[Valerie Yang MBBChir PhD @val_yang]

@oncodaily @astar_research @CellbiologyT Thank you @oncodaily for highlighting this important need!

[Inga-Marie Schaefer @im_schaefer]

‼️Coming up 🔜 @ctosociety Webinar on “Dedifferentiated Liposarcoma”- the 2024 #sarcoma of the year! Please join us for an in-depth overview of the state-of-the-art of DDLPS diagnostics, biology, and clinical management on October 10!

Register here👇
https://t.co/calRPfl1iA

[Valerie Yang MBBChir PhD @val_yang]

@irhkch Congratulations @irhkch !

[Valerie Yang MBBChir PhD @val_yang]

@careforhana @oncodaily Yes I absolutely agree. A massive challenge to put fragmented data together, what more in rare cancers. What applies to Asia also differs from MENA - biology aside, access, reimbursement and healthcare logistics also make a huge difference.

[OncoDaily @oncodaily]

🔈Dr. @val_yang introduces HaNSA—the Head and Neck Sarcoma Assessor. It's a game changer for guiding treatment decisions in rare cancers. Dive in and explore!

https://t.co/9tt2yAe839

#Cancer #HNCSM #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

[Valerie Yang MBBChir PhD @val_yang]

@saxotomy @pmcancercentre @lillian_siu @NationalLMSF Wowowow! Have a fantastic time Tom!!!

[Valerie Yang MBBChir PhD @val_yang]

No. HaNSA isn't the name of a Korean girl band🤣 It's the Head and Neck Sarcoma Assessor! This helps guide clinicians managing these rare cancers make treatment decisions. Scan the QR code to try this out for yourself!

https://t.co/KLuMU92oLs

#sarcoma #rarecancer #CTOSTweetos

[Valerie Yang MBBChir PhD @val_yang]

@herbloong @myESMO @ctosociety @DrCeSarcoma Keep us posted @herbloong! Would have loved to have been there!

[indicanews.com @indicanews1]

People diagnosed with rare cancers more prone to suicides, PTSD: Research
@val_yang 
#valerieyang #sohkimhai #nationalcancercentresingapore #nationaluniversityofsingapore #indicanews
https://t.co/nFvdZb8bXe

[OncoDaily @oncodaily]

Such a pleasure to chair the Sarcoma Track at the @SSO_Singapore Annual Scientific Meeting 2024 - @val_yang @ASCO @SingHealthSG @astar_research @oncodaily @JB_Chiang

https://t.co/cgkHEnHF2x

#ASCO #cancerCare #cancer #OncoDaily #Oncology #SingaporeSocietyofOncology

[OncoDaily @oncodaily]

To our patients: this may be rare, this may be challenging, but you are NOT alone - @val_yang
@csi_singapore @JohnnyOngCA @ChiaClaramae @JB_Chiang

https://t.co/XKomMD9Cka

#Cancer #SarcomaAwareness #PatientAdvocacy #RareCancer #OncoDaily #Oncology

[Sandra P D'Angelo, MD @sandrapdangelo]

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors.

https://t.co/URro4jvpTL

[Sarcoma Foundation of America @CureSarcoma]

Dr. Christopher Fletcher made an incredible impact on sarcoma research and the sarcoma community. We are deeply saddened by his passing and are immensely grateful for his remarkable contributions.

[SARC @SARCtrials]

Pictured here at the #SARCtrials Semi-Annual Meeting at #CTOS this past November, Dr. Chris Fletcher has had an astounding impact on #sarcoma research and the sarcoma community. We are saddened to learn of his passing and are grateful for his amazing contributions.